Provided By GlobeNewswire
Last update: Sep 4, 2025
VALENCIA, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today reaffirmed real-world data from the U.S. national burn registry demonstrating that the use of the RECELL® System significantly reduces hospital length of stay (LOS) by an average of 36% compared to traditional split thickness skin grafts (STSG) in adult patients with deep partial thickness (second degree) burns affecting up to 30% total body surface area. A greater proportion of RECELL-treated patients were discharged directly home, indicating improved recovery trajectories.
Read more at globenewswire.comNASDAQ:RCEL (9/29/2025, 12:42:06 PM)
5.52
+0.32 (+6.15%)
Find more stocks in the Stock Screener